Elevating Healthcare Strategy:
Unmasking Game-Changing Insights on GLP-1 & GIP/GLP-1 with Drug-GPT™ Technology
What's Inside
Working with our partners at Sermo, this report leverages Talking Medicines’ Drug-GPT™ and Sermo's Brand Pulse. We set out to better understand current challenges as well as perceptions, attitudes, and usage around GLP-1 and GIP/GIP-1 medications among patients and physicians.
Download this exclusive report to:
- Gain insight into how GLP-1 and GIP/GLP-1 drugs have revolutionized the type 2 diabetes space.
- Explore how physicians and patients alike are talking, thinking, and reacting to GLP-1 and GIP/GLP-1 medications.
- Deep dive into learnings about specific medications like semaglutide and tirzepatide both from the physician and patient perspective.